NOVELLO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 210
AS - Asia 164
EU - Europa 139
SA - Sud America 24
AF - Africa 2
Totale 539
Nazione #
US - Stati Uniti d'America 200
CN - Cina 73
IE - Irlanda 53
SG - Singapore 43
HK - Hong Kong 26
RU - Federazione Russa 24
BR - Brasile 21
DE - Germania 16
FI - Finlandia 16
IT - Italia 11
VN - Vietnam 10
CA - Canada 6
GB - Regno Unito 4
IN - India 4
ES - Italia 3
AR - Argentina 2
CH - Svizzera 2
FR - Francia 2
NL - Olanda 2
BD - Bangladesh 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
MA - Marocco 1
MX - Messico 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 539
Città #
Dublin 49
Ashburn 27
Beijing 27
Hong Kong 26
Dallas 25
Chandler 24
Singapore 12
Shanghai 11
Boardman 9
Helsinki 9
Los Angeles 9
Munich 9
Lawrence 7
Medford 7
Princeton 7
Turku 7
New York 5
Toronto 5
Moscow 4
Nanjing 4
Hanoi 3
Nanchang 3
Pavia 3
Redondo Beach 3
San Diego 3
Wilmington 3
Belo Horizonte 2
Brooklyn 2
Chicago 2
Frascati 2
Guangzhou 2
Hyderabad 2
Nuremberg 2
San Mateo 2
Shenyang 2
São José 2
São Paulo 2
The Dalles 2
Zurich 2
Amman 1
Amsterdam 1
Ankara 1
Aparecida de Goiânia 1
Auriflama 1
Baghdad 1
Bandung 1
Bell Ville 1
Belém 1
Bonito 1
Boston 1
Brasília 1
Brazzaville 1
Buffalo 1
Campina Grande 1
Caracas 1
Chennai 1
Columbus 1
Dehradun 1
Denver 1
Dhaka 1
Dinuba 1
Douglas 1
Dourados 1
Düsseldorf 1
Elk Grove Village 1
Fernandópolis 1
Floriano 1
Frankfurt am Main 1
Gary 1
Hangzhou 1
Hebei 1
Ho Chi Minh City 1
Jacksonville 1
Lahore 1
Langhorne 1
London 1
Lấp Vò 1
Managua 1
Manchester 1
Massena 1
Medina 1
Merate 1
Meriden 1
Mexico City 1
Milan 1
Mogi das Cruzes 1
Monmouth Junction 1
Montego Bay 1
Norfolk 1
Olomouc 1
Oslo 1
Panama City 1
Petrolândia 1
Quanzhou 1
Queens 1
Resistencia 1
Rio de Janeiro 1
San Francisco 1
Santa Clara 1
Santa Maria 1
Totale 388
Nome #
Lung Cancer App (LuCApp) study protocol: A randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 79
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 79
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 54
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 54
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer 53
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 52
Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017)) 49
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling 49
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? 48
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 33
Totale 550
Categoria #
all - tutte 2.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 1 0 4 0 0 0 0 2 2 10 6 14
2022/202392 12 10 0 7 3 1 0 2 50 0 7 0
2023/202475 13 10 6 3 8 14 3 2 0 13 1 2
2024/2025148 2 10 0 0 0 3 11 14 41 8 15 44
2025/2026175 43 12 45 20 54 1 0 0 0 0 0 0
Totale 550